Find Research outputs

Search results

• A comparison of red blood cell transfusion utilization between anti-activated factor X and activated partial thromboplastin monitoring in patients receiving unfractionated heparin

  Belk, K. W., Laposata, M. & Craver, C., Nov 1 2016, In: Journal of Thrombosis and Haemostasis. 14, 11, p. 2148-2157 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Factor Xa
  • Erythrocyte Transfusion
  • Thromboplastin
  • Physiologic Monitoring
  • Heparin
  5 Scopus citations

• A manifesto for the future of laboratory medicine professionals

  Plebani, M., Laposata, M. & Lippi, G., Feb 2019, In: Clinica Chimica Acta. 489, p. 49-52 4 p.

  Research output: Contribution to journal › Editorial › peer-review

  • Medicine
  • Laboratory Personnel
  • Delivery of Health Care
  • Health care
  • Testing
  32 Scopus citations

• A prospective tool for risk assessment of sendout testing

  Cole, B., Dickerson, J. A., Graber, M. L., Fantz, C. R., Laposata, M., Henriksen, K., Astion, M. L. & Epner, P., Jul 1 2014, In: Clinica Chimica Acta. 434, p. 1-5 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Risk assessment
  • Patient Harm
  • Risk Assessment
  • Testing
  • Quality Improvement
  4 Scopus citations

• Attitudes of clinicians following large-scale pharmacogenomics implementation

  Peterson, J. F., Field, J. R., Shi, Y., Schildcrout, J. S., Denny, J. C., McGregor, T. L., Van Driest, S. L., Pulley, J. M., Lubin, I. M., Laposata, M., Roden, D. M. & Clayton, E. W., Aug 1 2016, In: Pharmacogenomics Journal. 16, 4, p. 393-398 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Pharmacogenetics
  • Pharmacogenomic Variants
  • Prescriptions
  • Drug Interactions
  • Motivation
  39 Scopus citations

• DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activity

  Njoroge, S. W., Laposata, M., Katrangi, W. & Seegmiller, A. C., Feb 2012, In: Journal of Lipid Research. 53, 2, p. 257-265 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Docosahexaenoic Acids
  • Cystic Fibrosis
  • Fatty Acids
  • Metabolism
  • Fatty Acid Desaturases
  42 Scopus citations

• Driving the route of laboratory medicine: a manifesto for the future

  Plebani, M., Laposata, M. & Lippi, G., Jan 1 2019, In: Internal and Emergency Medicine.

  Research output: Contribution to journal › Article › peer-review

  • Medicine
  • Patient Rights
  • Clinical Decision-Making
  • Organizations
  • Delivery of Health Care
  10 Scopus citations

• Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study

  O'Connor, M. G., Thomsen, K., Brown, R. F., Laposata, M. & Seegmiller, A., Oct 1 2016, In: Prostaglandins Leukotrienes and Essential Fatty Acids. 113, p. 46-49 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Metabolites
  • Pediatrics
  • Prostaglandins E
  • Docosahexaenoic Acids
  • Cystic Fibrosis
  4 Scopus citations

• Insufficient Teaching of Laboratory Medicine in US Medical Schools

  Laposata, M., 2016, In: Academic Pathology. 3

  Research output: Contribution to journal › Comment/debate › peer-review
  5 Scopus citations

• It's our turn: Implications for pathology from the Institute of Medicine's report on diagnostic error

  Laposata, M. & Cohen, M. B., Jun 2016, In: Archives of Pathology and Laboratory Medicine. 140, 6, p. 505-507 3 p.

  Research output: Contribution to journal › Editorial › peer-review
  6 Scopus citations

• Operational implementation of prospective genotyping for personalized medicine: The design of the vanderbilt PREDICT project

  Pulley, J. M., Denny, J. C., Peterson, J. F., Bernard, G. R., Vnencak-Jones, C. L., Ramirez, A. H., Delaney, J. T., Bowton, E., Brothers, K., Johnson, K., Crawford, D. C., Schildcrout, J., Masys, D. R., Dilks, H. H., Wilke, R. A., Clayton, E. W., Shultz, E., Laposata, M., McPherson, J., Jirjis, J. N. & 1 others, Roden, D. M., Jul 2012, In: Clinical Pharmacology and Therapeutics. 92, 1, p. 87-95 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Precision Medicine
  • Clopidogrel
  • Point-of-Care Systems
  • Cytochrome P-450 CYP2C19
  • Clinical Decision Support Systems
  265 Scopus citations

• Physician Response to Implementation of Genotype-Tailored Antiplatelet Therapy

  Peterson, J. F., Field, J. R., Unertl, K. M., Schildcrout, J. S., Johnson, D. C., Shi, Y., Danciu, I., Cleator, J. H., Pulley, J. M., McPherson, J. A., Denny, J. C., Laposata, M., Roden, D. M. & Johnson, K. B., Jul 1 2016, In: Clinical Pharmacology and Therapeutics. 100, 1, p. 67-74 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Cytochrome P-450 CYP2C19
  • Genotype
  • Physicians
  • Clopidogrel
  • Cardiologists
  33 Scopus citations

• Putting the patient first - Using the expertise of laboratory professionals to produce rapid and accurate diagnoses

  Laposata, M., Dec 1 2014, In: Laboratory medicine. 45, 1, p. 4-5 2 p.

  Research output: Contribution to journal › Editorial › peer-review
  11 Scopus citations

• Reducing diagnostic errors worldwide through diagnostic management teams

  Verna, R., Velazquez, A. B. & Laposata, M., 2019, In: Annals of Laboratory Medicine. 39, 2, p. 121-124 4 p.

  Research output: Contribution to journal › Review article › peer-review

  • Diagnostic Errors
  • Delivery of Health Care
  • Budgets
  • Italy
  • Clinical laboratories
  8 Scopus citations

• Teaching laboratory management to pathology residents

  Laposata, M., Jan 2012, In: American journal of clinical pathology. 137, 1, p. 16-18 3 p.

  Research output: Contribution to journal › Editorial › peer-review
  3 Scopus citations

• Test of the month: The chromogenic antifactor Xa assay

  Gehrie, E. & Laposata, M., Feb 2012, In: American Journal of Hematology. 87, 2, p. 194-196 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Anticoagulants
  • Fondaparinux
  • Rivaroxaban
  • Partial Thromboplastin Time
  • Low Molecular Weight Heparin
  33 Scopus citations

• The identification and management of heparin-induced thrombocytopenia in the vascular patient

  Lamuraglia, G. M., Houbballah, R. & Laposata, M., Feb 2012, In: Journal of vascular surgery. 55, 2, p. 562-570 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Thrombocytopenia
  • Heparin
  • Blood Vessels
  • Platelet Factor 4
  • Platelet Count
  11 Scopus citations

• The Value Proposition for Pathologists: A Population Health Approach

  Ducatman, B. S., Ducatman, A. M., Crawford, J. M., Laposata, M. & Sanfilippo, F., 2020, In: Academic Pathology. 7

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Population Health
  • Pathologists
  • Delivery of Health Care
  • Precision Medicine
  • Diagnostic Errors
  1 Scopus citations